Drug Shortage Report for SYLVANT
Report ID | 252358 |
Drug Identification Number | 02435136 |
Brand name | SYLVANT |
Common or Proper name | SYLVANT |
Company Name | RECORDATI RARE DISEASES CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SILTUXIMAB |
Strength(s) | 400MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 1 X 30 ML vial |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2025-03-06 |
Estimated end date | 2025-03-31 |
Actual end date | 2025-03-27 |
Shortage status | Resolved |
Updated date | 2025-03-28 |
Company comments | 100 mg/vial strength is available for distribution and can be used in place of the 400 mg/vial until the stock is available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3080 YONGE STREET, SUITE 6060 TORONTO, ONTARIO CANADA M4N 3N1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-03-28 | English | Compare |
v3 | 2025-03-27 | English | Compare |
v2 | 2025-03-11 | French | Compare |
v1 | 2025-03-11 | English | Compare |
Showing 1 to 4 of 4